Canada
· Delayed Price · Currency is CAD Titan Medical Statistics
Total Valuation
Titan Medical has a market cap or net worth of CAD 5.13 million. The enterprise value is 1.28 million.
| Market Cap | 5.13M |
| Enterprise Value | 1.28M |
Important Dates
The last earnings date was Monday, November 11, 2024.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Titan Medical has 4.56 million shares outstanding. The number of shares has increased by 1.43% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 4.56M |
| Shares Change (YoY) | +1.43% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 10.11% |
| Owned by Institutions (%) | 3.95% |
| Float | 113.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.31 |
| PB Ratio | 1.37 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.17 |
| EV / Sales | 2.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.73, with a Debt / Equity ratio of 0.40.
| Current Ratio | 3.73 |
| Quick Ratio | 3.42 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.03 |
Financial Efficiency
Return on equity (ROE) is -106.83% and return on invested capital (ROIC) is -26.26%.
| Return on Equity (ROE) | -106.83% |
| Return on Assets (ROA) | -20.00% |
| Return on Invested Capital (ROIC) | -26.26% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 153,973 |
| Profits Per Employee | -1.92M |
| Employee Count | 4 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.29% in the last 52 weeks. The beta is 1.98, so Titan Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.98 |
| 52-Week Price Change | -64.29% |
| 50-Day Moving Average | 1.30 |
| 200-Day Moving Average | 1.65 |
| Relative Strength Index (RSI) | 48.30 |
| Average Volume (20 Days) | 2,008 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Titan Medical had revenue of CAD 615,893 and -7.67 million in losses. Loss per share was -1.84.
| Revenue | 615,893 |
| Gross Profit | 615,893 |
| Operating Income | -3.80M |
| Pretax Income | -7.63M |
| Net Income | -7.67M |
| EBITDA | -3.51M |
| EBIT | -3.80M |
| Loss Per Share | -1.84 |
Balance Sheet
The company has 5.36 million in cash and 1.50 million in debt, giving a net cash position of 3.86 million or 0.85 per share.
| Cash & Cash Equivalents | 5.36M |
| Total Debt | 1.50M |
| Net Cash | 3.86M |
| Net Cash Per Share | 0.85 |
| Equity (Book Value) | 3.74M |
| Book Value Per Share | 0.82 |
| Working Capital | 4.45M |
Cash Flow
| Operating Cash Flow | -8.57M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -617.56% |
| Pretax Margin | -1,239.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Titan Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.43% |
| Shareholder Yield | -1.43% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 19, 2018. It was a reverse split with a ratio of 0.0333333.
| Last Split Date | Jun 19, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.0333333 |
Scores
Titan Medical has an Altman Z-Score of -88.44. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -88.44 |
| Piotroski F-Score | n/a |